Libby's H*O*P*E*

*Helping*Ovarian Cancer Survivors*Persevere Through*Education

Menu

Skip to content
  • Home
  • About
  • Mission
  • Warning Signs & Symptoms
  • Ovarian Cancer Overview
  • Prevention, Early Detection/Screening & Causes
  • Genetics
  • Types of Ovarian Cancer
  • Diagnosis & Staging
  • Treatment Overview
  • Surgery
  • Chemotherapy
  • Radiology & Radiation Therapy
  • Hormonal (Anti-Estrogen) Therapy
  • Biological (Immunotherapy & Vaccine) Therapy
  • Gene Therapy
  • Alternative & Complementary Therapy
  • Clinical Development
  • Clinical Trials
  • Coping
  • Survivorship
  • Ovarian Cancer Resources
  • Contact

Tag Archives: Good Enough Mama

Vox Populi*: A Daughter’s Thoughts On The 5th Anniversary of Her Mother’s Death From Ovarian Cancer

Posted on May 31, 2009 by Paul Cacciatore

Vox Populi*:  A Daughter’s Thoughts On the 5th Anniversary of Her Mother’s Death From Ovarian Cancer

Continue reading →

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • Share on Pinterest (Opens in new window) Pinterest
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Tumblr (Opens in new window) Tumblr
  • Share on Reddit (Opens in new window) Reddit
  • Print (Opens in new window) Print
  • Email a link to a friend (Opens in new window) Email
Like Loading...
Posted in Vox Populi | Tagged Five Years, Good Enough Mama, Mommy Vents, ovarian cancer, Vox Populi | Leave a comment
"Once you choose hope, anything is possible." -- Christopher Reeve

Categories

RSS Google Ovarian Cancer News

  • Nearly half of ovarian cancer cases are diagnosed in ER, missing critical treatment window, study finds - ABC News - Breaking News, Latest News and Videos
  • PRC2 governs HR proficiency and chemosensitivity in ovarian cancer via SQSTM1-mediated chromatin ubiquitination - Nature
  • Runcie C.W. Chidebe: Last Call for Nominations for the World Ovarian Cancer Coalition Impact Awards 2026 - Oncodaily
  • Six years, one lab: How a summer internship led to a Ph.D. in ovarian cancer research - University of Arizona News
  • Novel ADCs Show Responses in Ovarian and Cervical Cancer at ESMO 2026 - Targeted Oncology
  • Personalized ovarian cancer vaccines spark immunity in phase 1 trial - Medical Xpress
  • Rinatabart Sesutecan for Patients With Platinum-Resistant Ovarian Cancer: First Efficacy and Safety Results From the Phase 2 Cohort of the RAINFOL-01 Study - OncLive
  • Epidermal Growth Factor Receptor (EGFR) Mutations in Rare Histological Subtypes of Ovarian Cancer - Cureus
  • ESMO: Lilly touts 79% ADC response rate in competitive ovarian cancer space - Fierce Biotech
  • The surprising link between ovarian cancer and the fallopian tubes - Harvard Health

Top Posts

  • CNTO 328 Shows Promise For Ovarian Cancer In Small Clinical Trial, Say U.K. Scientists.
    CNTO 328 Shows Promise For Ovarian Cancer In Small Clinical Trial, Say U.K. Scientists.
  • About
    About
  • U.S. President Barack Obama Proclaims September 2013 As National Ovarian Cancer Awareness Month — What Should You Know?
    U.S. President Barack Obama Proclaims September 2013 As National Ovarian Cancer Awareness Month — What Should You Know?
  • The Mirror: "What is the Meaning of Life?"
    The Mirror: "What is the Meaning of Life?"
  • Combination Targeted Therapy With Sorafenib & Bevacizumab Shows Antitumor Activity
    Combination Targeted Therapy With Sorafenib & Bevacizumab Shows Antitumor Activity
  • Take The "Check-Up Day Pledge" and Register For the "Woman Challenge" During Women's National Health Week
    Take The "Check-Up Day Pledge" and Register For the "Woman Challenge" During Women's National Health Week
  • 2011 ASCO Annual Meeting Abstracts (Including Ovarian Cancer) Made Publicly Available Today
    2011 ASCO Annual Meeting Abstracts (Including Ovarian Cancer) Made Publicly Available Today
  • New Monoclonal Antibody Offers Hope In the Fight Against Ovarian Cancer
    New Monoclonal Antibody Offers Hope In the Fight Against Ovarian Cancer
  • 2011 ASCO: Women with BRCA Gene Mutations Can Take Hormone-Replacement Therapy Safely After Ovary Removal
    2011 ASCO: Women with BRCA Gene Mutations Can Take Hormone-Replacement Therapy Safely After Ovary Removal
  • Ampligen® To Be Tested In Phase I/II Study In Tandem With UPenn Ovarian Cancer Vaccine
    Ampligen® To Be Tested In Phase I/II Study In Tandem With UPenn Ovarian Cancer Vaccine

Archives

  • May 2015
  • September 2014
  • August 2014
  • May 2014
  • March 2014
  • August 2013
  • May 2013
  • February 2013
  • January 2013
  • July 2012
  • June 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008

Blog Stats

  • 514,825 Visitors
cancer blog

Enter your email address to subscribe to Libby's H*O*P*E* & receive notifications of new posts by email.

Join 341 other subscribers

 Subscribe in a reader

Click on the orange button above if you want to (i) add Libby's H*O*P*E*(tm) updates to a web-based or other reader, or (ii) embed a Libby's H*O*P*E* (tm) update widget on your desktop, website or blog.

Donate To Ovarian Cancer Research

OCRF is the largest U.S. private funding agency supporting ovarian cancer research. It is a not-for-profit, 501(c)(3) organization. Click on the OCRF logo above to make a donation.

Strategic Partners

Podcasts

Join Us In the Fight Against Ovarian Cancer

RSS New Ovarian Cancer Clinical Trials (Past 14 Days)

  • Phase 1 Study of VT-101 in Advanced Ovarian Cancer
  • Methylation Profiling in Self-samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
  • A Study of MDSY-1240, a STAT3 Degrader, for the Treatment of Hematologic Malignancies and Advanced Solid Tumors
  • Feasibility of the "One-Finger Technique" for Identifying the Upper Left Ureter During Para-Aortic Lymphadenectomy
  • A Study to Evaluate YF550 in Participants With Locally Advanced or Metastatic Solid Tumors.
  • Effects of Web-Based Ovarian Cancer Awareness Education on Women's Health Beliefs and Risk-Reducing Behaviors

RSS New Adult Solid Tumor Clinical Trials (Past 14 Days)

  • A Study of JNJ-101556143 With Best Supportive Care in Participants With Metastatic Prostate Cancer
  • Deutenzalutamide and Hormone Therapy Before and After Surgery With Docetaxel Before Surgery for High-Risk Localized or Locally Advanced Prostate Cancer
  • A Study to Evaluate the Safety and Effectiveness of Different Doses of RO7836748 Alone or in Combination With Other Cancer Therapies in People With Solid Tumors With a Rat Sarcoma Viral Oncogene Homolog Glycine 12 Valine (RAS G12V) Mutation
  • First-in-Human, Multicenter, Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of YL-18319 Monotherapy in Patients With Locally Advanced/Metastatic Solid Tumors
  • A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.
  • A Study of BON-C1393 in Adults With Advanced Solid Tumors
  • Becotatug Vedotin Plus Gemcitabine and a PD-1 Inhibitor in Recurrent or Metastatic Nasopharyngeal Carcinoma
  • SND002 Cell Injection in Participants With Advanced Malignant Solid Tumors
  • A Study of IBI3043 Treatment in Participants With Locally Advanced, Unresectable or Metastatic Solid Tumors
  • Phase 1 Study of VT-101 in Advanced Ovarian Cancer

RSS Medical Studies

  • Thoracic recurrence after complete gross resection in advanced ovarian cancer: The clinical impact of occult subdiaphragmatic lymphatic invasion
  • Defining quality care in gynecologic cancers: A Society of Gynecologic Oncology review
  • How patients with advanced gynecological cancer perceive clinicians' attention to their values, wishes, and needs: a qualitative study
  • Clinical outcomes of 5-day administration of topotecan combined with bevacizumab for platinum-resistant ovarian cancer: a multicenter retrospective analysis
  • Near-Infrared Light-Responsive Liposomes for Modulating Switchable CAR-T Cell Therapy
  • Mechanical dysfunction: ovarian cancer ascites disables NK cells by suppressing CDC42-driven force generation
  • Injectable and Bio-responsive Hydrogels for On-Demand Intraperitoneal Delivery of Anti-Cancer Therapeutics in Ovarian Cancer
  • Gender differences in academic visibility and leadership at European Society of Gynaecological Oncology-endorsed events
  • Cancer stem cell marker CD44 in epithelial ovarian tumors: Association with adverse prognostic features in invasive carcinomas
  • Survival After Risk-Reducing Mastectomy in Patients With Pathogenic Variants in BRCA1 and BRCA2: A Network Meta-Analysis

Recent Comments

Prometey Bank's avatarPrometey Bank on World Ovarian Cancer Day: Toge…
mikaljhohnashly's avatarmikaljhohnashly on World Ovarian Cancer Day: Toge…
Jan C. Calthrop's avatarJan C. Calthrop on Lab-On-A-Chip: Veridex & M…
Paul Cacciatore's avatarPaul Cacciatore on About
Building a Team for… on About
Kathleen's avatarKathleen on About
Paul Cacciatore's avatarPaul Cacciatore on About
Liz's avatarLiz on About
Paul Cacciatore's avatarPaul Cacciatore on Dana Farber Webchat: The Lates…
Judith Marengere's avatarJudith Marengere on Dana Farber Webchat: The Lates…
Paul Cacciatore's avatarPaul Cacciatore on Dana Farber Webchat: The Lates…
Franca Pichini's avatarFranca Pichini on Dana Farber Webchat: The Lates…
painspeaks's avatarpainspeaks on SU2C Announces the Formation o…
marcy westerling's avatarmarcy westerling on SU2C Announces the Formation o…
anne's avataranne on Dana-Farber Oncologists Differ…

Blogroll

  • Site Meter Site Meter

Cancer Organizations

  • American Cancer Society
  • National Cancer Institute

Everyday Heroes

  • Are You There Cancer? It's Me, Jennie.
  • Bald Heads Are Sexy
  • Butterfly Ballet
  • Cancer Queen
  • Carrie's Journey
  • Chris Bledy
  • Diary of a Cancer Patient
  • I Want To Breathe
  • Janine's News
  • Journey Through Ovarian Cancer
  • Kristi & Brian: Living! With Cancer
  • Laurey Bikes
  • Life Cycle
  • livingly dying
  • Marcheline Bertrand Remembered
  • Meghan's Message
  • Monday Hearts For Madalene
  • My Journey With Teal
  • Nobody Has Ovarian Cancer
  • Out Shine Ovarian Cancer
  • OVACOM
  • Ovarian Cancer News
  • Ovarian Cancer?? pass the wine … now!
  • Scrambled Eggs, Surviving Ovarian Cancer
  • Shannon Miller Lifestyle
  • Still Smiling
  • Strong As Steele
  • Tenaciously Teal
  • The Carcinista
  • What? Me Worry?
  • Will There Be Cows In Heaven?
  • Women of Teal

Inspirational Cancer Advocates

  • Bald Is Beautiful
  • Bicycling For Ovarian Cancer (Craig Broeder)
  • Christine Druther
  • Fran Drescher
  • Imerman Angels
  • Jenn Sommermann: Training For a Cure
  • Jim Valvano
  • Laurey Masterton
  • Maddie Kullen
  • Mothers With Cancer
  • Randy Pausch
  • Sean Swarner
  • Standup2cancer
  • The Rock Band N.E.D.

Ovarian Cancer News Archive

  • Ovarian Cancer News Archive

Ovarian Cancer Organizations

  • National Breast & Ovarian Cancer Connection
  • National Ovarian Cancer Coalition
  • Ovarian Cancer National Alliance
  • Ovarian Cancer Research Fund
  • Ovations For the Cure

U.S. Treatment Centers

  • National Comprehensive Cancer Network Member Institutions
  • NCI-Designated Cancer Centers

Video Archive

  • Ovarian Cancer Video Library
Copyright 2008 - 2016 Paul Cacciatore, Libby's H*O*P*E*(TM), *Helping *Ovarian Cancer Survivors *Persevere Through *Education(TM), all rights reserved.
Paul Cacciatore

Create Your Badge
Site Meter
Blog at WordPress.com.
  • Subscribe Subscribed
    Libby's H*O*P*E*
    Join 216 other subscribers

    Have a WordPress.com account? Log in now.

  • Libby's H*O*P*E*
    View site in Reader
    Manage subscriptionsSign upLog in
    Report this content
    Collapse this bar
%d